Researchers with Somalogic, Inc. have recently developed new technology that may enable oncologists to earlier diagnose two types of rare cancer, mesothelioma and pancreatic cancer. The test has thus far proven to be highly accurate, measuring changes in the blood that detect mesothelioma in its earliest stages, when treatment is expected to be more successful.
TestimonialsMy situation, which was most difficult because of having to deal with multiple defendants and sub co-defendants, illustrated how well you handled each and every situation in bringing this legal battle to a very satisfactory closure."
Greg & Claire
Chester, New Jersey
News by Topic